Shefali Luthra

Shefali Luthra was a correspondent for KFF Health News until June 2020.

@shefalil

Bubble Pop? Brownie Batter? Vapes’ Added Flavors Fuel E-Cig Debate

Vaping is becoming increasingly popular in the United States, especially among young people. This fact is triggering an unexpected divide within the public health community and complicating efforts to regulate the industry.

‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High

The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.

Congress Tackles The Opioid Epidemic. But How Much Will It Help?

President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.